Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Decellularized homografts have shown auspicious early results when used for pulmonary valve replacement (PVR) in congenital heart disease. The first clinical application in children was performed in 2002, initially using pre-seeding with endogenous progenitor cells. Since 2005, only non-seeded, fresh decellularized allografts have been implanted after spontaneous recellularization was observed by several groups. METHODS: A matched comparison of decellularized fresh pulmonary homografts (DPHs) implanted for PVR with cryopreserved pulmonary homografts (CHs) and bovine jugular vein conduits (BJVs) was conducted. Patients' age at implantation, the type of congenital malformation, number of previous cardiac operations and number of previous PVRs were considered for matching purposes, using an updated contemporary registry of right ventricular outflow tract conduits (2300 included conduits, >12 000 patient-years). RESULTS: A total of 131 DPHs were implanted for PVR in the period from January 2005 to September 2015. Of the 131, 38 were implanted within prospective trials on DPH from October 2014 onwards and were therefore not analysed within this study. A total of 93 DPH patients (58 males, 35 females) formed the study cohort and were matched to 93 CH and 93 BJV patients. The mean age at DPH implantation was 15.8 ± 10.21 years (CH 15.9 ± 10.4, BJV 15.6 ± 9.9) and the mean DPH diameter was 23.9 mm (CH 23.3 ± 3.6, BJV 19.9 ± 2.9). There was 100% follow-up for DPH, including 905 examinations with a mean follow-up of 4.59 ± 2.76 years (CH 7.4 ± 5.8, BJV 6.4 ± 3.8), amounting to 427.27 patient-years in total (CH 678.3, BJV 553.0). Tetralogy-of-Fallot was the most frequent malformation (DPH 50.5%, CH 54.8%, BJV 68.8%). At 10 years, the rate of freedom of explantation was 100% for DPH, 84.2% for CH (P = 0.01) and 84.3% for BJV (P= 0.01); the rate of freedom from explantation and peak trans-conduit gradient ≥50 mmHg was 86% for DPH, 64% for CH (n.s.) and 49% for BJV (P < 0.001); the rate of freedom from infective endocarditis (IE) was 100% for DPH, 97.3 ± 1.9% within the matched CH patients (P = 0.2) and 94.3 ± 2.8% for BJV patients (P = 0.06). DPH valve annulus diameters converged towards normal Z-values throughout the observation period, in contrast to other valve prostheses (BJV). CONCLUSIONS: Mid-term results of DPH for PVR confirm earlier results of reduced re-operation rates compared with CH and BJV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulmonary Valve Replacement After Operative Repair of Tetralogy of Fallot
Ferraz Cavalcanti, P. E., Sá, M. P. B. O., Santos, C. A., Esmeraldo, I. M., Escobar, R. R. D., Menezes, A. M. D., Azevedo, O. M. D., Vasconcelos Silva, F. P. D., Lins, R. F. D. A., & Lima, R. D. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.107 · Cited by 267
Cited by
Porzionato, A., Stocco, E., Barbon, S., Grandi, F., Macchi, V., & De Caro, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124117 · Cited by 319
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity
Fioretta, E. S., Motta, S. E., Lintas, V., Loerakker, S., Parker, K. K., Baaijens, F. P. T., Falk, V., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0422-8 · Cited by 262
Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve
VeDepo, M. C., Detamore, M. S., Hopkins, R. A., & Converse, G. L. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417726327 · Cited by 117
Goecke, T., Theodoridis, K., Tudorache, I., Ciubotaru, A., Cebotari, S., Ramm, R., Höffler, K., Sarikouch, S., Vásquez Rivera, A., Haverich, A., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.041 · Cited by 60
Self-citationRamm, R., Goecke, T., Theodoridis, K., Hoeffler, K., Sarikouch, S., Findeisen, K., Ciubotaru, A., Cebotari, S., Tudorache, I., Haverich, A., et al. (2020) · Xenotransplantation · doi:10.1111/xen.12571 · Cited by 59
Self-citation
Metadata
- Authors
- Sarikouch, S., Horke, A., Tudorache, I., Beerbaum, P., Westhoff-Bleck, M., Boethig, D., Repin, O., Maniuc, L., Ciubotaru, A., Haverich, A., & Cebotari, S.
- Venue
- European Journal of Cardio-Thoracic Surgery
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-24
- Volume
- 50
- Issue
- 2
- Pages
- 281-290
- ISSN
- 1010-7940 (ISSN-L)
- 1873-734X
- OpenAlex
- W2310774765
- Cited by
- 159
- References
- 1
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. https://app.cochat.ai/papers/10.1093/ejcts/ezw050
- The paper
- Sarikouch, S., Horke, A., Tudorache, I., Beerbaum, P., Westhoff-Bleck, M., Boethig, D., Repin, O., Maniuc, L., Ciubotaru, A., Haverich, A., & Cebotari, S. (2016). Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezw050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.